Benzinga | Jan 27, 2022 04:11PM EST

Nurix Therapeutics Q4 EPS $(0.85) Down From $(0.51) YoY, Sales $7.40M Up From $6.69M YoY

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.85) per share. This is a 66.67 percent decrease over losses of $(0.51) per share from the same period last year. The company reported $7.40 million in sales this quarter. This is a 10.57 percent increase over sales of $6.69 million the same period last year.